Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin(Southeast University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Zhuopei Li(Nanjing Medical University), Hongxing Pan(Jiangsu Provincial Center for Disease Control and Prevention), Shipo Wu(Academy of Military Medical Sciences), Rong Tang(Jiangsu Provincial Center for Disease Control and Prevention), Yin Chen(Zhejiang Ocean University), Jin Zhong, Jin-Bo Gou, Jialu Feng(Nanjing Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Tao Zhu, Xue Wang(Ningxia Hui Autonomous Region Peoples Hospital), Xiaoqin Chen(North Sichuan Medical University), Xiaoyin Zhang(Southeast University), Xin Xia(Nanjing Medical University), Jingxin Li(Beijing Tongren Hospital), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Wei Chen(Academy of Military Medical Sciences), Lihua Hou(Academy of Military Medical Sciences), Xiaoyu Xu, Qi Zhao(CanSino (China))
Cited by 10
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
Methanotrophs: Multifunctional bacteria with promising applications in environmental bioengineering
|Biochemical Engineering Journal|2010|208